Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 381 entries
View as:

RFA Using Multi-Tined Electrodes vs.Traditional Electrodes for Lumbar Spondylosis

Phase: N/A Priority: Normal
NCT ID: NCT06477094 Org: User:
Start: 08/09/24 End: 07/01/26 Due: 07/01/27

Evaluating the Use of ProKera Plus® in the Management of Bacterial Corneal Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT04850313 Org: User:
Start: 11/09/21 End: 09/30/22 Due: 09/30/23

Determine the Clinical Effectiveness of Mobile CenteringPregnancy to Improve Maternal and Infant Health Outcomes of Marshallese in Arkansas

Phase: N/A Priority: Normal
NCT ID: NCT07011121 Org: User:
Start: 05/01/24 End: 03/01/26 Due: 03/01/27

Narcotic Free TIVA and Incidence of Unacceptable Movements Under Anesthesia During ACDF Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03643796 Org: User:
Start: 07/15/18 End: 07/05/22 Due: 07/05/23

Neuropathic Pain in Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT02608463 Org: User:
Start: 01/01/16 End: 04/19/19 Due: 04/19/20

Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization

Phase: N/A Priority: Normal
NCT ID: NCT01449539 Org: User:
Start: 02/29/12 End: 06/30/13 Due: 06/30/14

Does Alkalinization Reduce Perceived Pain Levels During Sentinel Lymph Node Imaging?

Phase: N/A Priority: Normal
NCT ID: NCT01660412 Org: User:
Start: 08/01/12 End: 12/30/16 Due: 12/30/17

Telehealth Multi-Component Optional Model (MOM) Study

Phase: N/A Priority: Normal
NCT ID: NCT06095960 Org: User:
Start: 02/12/24 End: 12/31/27 Due: 12/31/28

Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01177735 Org: User:
Start: 10/31/11 End: 09/30/13 Due: 09/30/14

2015-10: Expanded Natural Killer Cells and Elotuzumab for High-Risk Myeloma Post- Autologous Stem Cell Transplant (ASCT)

Phase: N/A Priority: Normal
NCT ID: NCT03003728 Org: User:
Start: 11/01/19 End: 07/08/20 Due: 07/08/21

Methamphetamine-Quetiapine Interactions in Humans

Phase: N/A Priority: Normal
NCT ID: NCT00567866 Org: User:
Start: 01/31/08 End: 09/30/09 Due: 09/30/10

Nutritional Risk and Mucositis in Patients With Head and Neck Carcinoma Receiving Chemoradiation

Phase: N/A Priority: Normal
NCT ID: NCT00577902 Org: User:
Start: 06/30/05 End: 11/30/10 Due: 11/30/11

Treatment Outcomes With tDCS in Post-Stroke Aphasia

Phase: N/A Priority: Normal
NCT ID: NCT03929432 Org: User:
Start: 09/03/19 End: 12/31/27 Due: 12/31/28

Axillary Reverse Mapping

Phase: N/A Priority: Normal
NCT ID: NCT00572481 Org: User:
Start: 05/31/07 End: 02/28/26 Due: 02/28/27

Epigenetic Mechanisms and Symptom Clusters Associated with Resolution of Pain Following Spinal Cord Stimulation

Phase: N/A Priority: Normal
NCT ID: NCT04960592 Org: User:
Start: 02/15/21 End: 07/01/24 Due: 07/01/25

Comparing the Franseen and Fork-top Needles for EUS-guided Fine-needle Biopsy of Solid Mass Lesions.

Phase: N/A Priority: Normal
NCT ID: NCT03561038 Org: User:
Start: 04/01/19 End: 04/01/19 Due: 04/01/20

Food Provision in CenteringPregnancy Prenatal Care

Phase: N/A Priority: Normal
NCT ID: NCT06711627 Org: User:
Start: 06/30/25 End: 03/31/28 Due: 03/31/29

Self-affirmation Intervention for People Newly Diagnosed With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05235750 Org: User:
Start: 05/27/22 End: 07/07/23 Due: 07/07/24

Home Food Delivery for Diabetes Management in Patients of Rural Clinics

Phase: N/A Priority: Normal
NCT ID: NCT04876053 Org: User:
Start: 10/22/21 End: 02/06/26 Due: 02/06/27

Plasma Concentration of Biological Markers in Placental Abruption

Phase: N/A Priority: Normal
NCT ID: NCT03782168 Org: User:
Start: 01/31/19 End: 08/01/21 Due: 08/01/22

Head and Neck Cancer Screening and Serum Repository

Phase: N/A Priority: Normal
NCT ID: NCT00592371 Org: User:
Start: 03/31/06 End: 09/30/12 Due: 09/30/13

Video-based, Patient-Focused Opioid Education in the Perioperative Period

Phase: N/A Priority: Normal
NCT ID: NCT03986866 Org: User:
Start: 04/29/19 End: 04/01/20 Due: 04/01/21

Regulating Homeostatic Plasticity and the Physiological Response to rTMS

Phase: N/A Priority: Normal
NCT ID: NCT03309696 Org: User:
Start: 11/16/17 End: 10/01/19 Due: 10/01/20

A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework

Phase: N/A Priority: Normal
NCT ID: NCT06461416 Org: User:
Start: 06/10/24 End: 12/30/25 Due: 12/30/26

UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01313897 Org: User:
Start: 01/31/11 End: 10/31/16 Due: 10/31/17